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Abstract: Renal injury observed in several pathologies has been associated with lipid accumulation
in the kidney. While it has been suggested that the accumulation of renal lipids depends on free
fatty acids released from adipose tissue, it is not known whether in situ renal lipogenesis due to
endoplasmic reticulum (ER) stress contributes to kidney injury. The aim of the present study was
to elucidate the role of pharmacological ER stress in renal structure and function and its effect on
renal lipid metabolism of C57BL/6 mice. ER stress increased serum creatinine and induced kidney
structural abnormalities. Tunicamycin-administered mice developed hyperinsulinemia, augmented
lipolysis and increased circulating leptin and adiponectin. Renal unfolded protein response (UPR)
gene expression markers, the lipogenic transcription factor SREBP1 and the phosphorylation of
eIF2α increased 8 h after tunicamycin administration. At 24 h, an increase in BiP protein content
was accompanied by a reduction in p-eIF2α and increased SREBP-1 and FASn protein content, in
addition to a significant increase in triglyceride content and a reduction in AMPK. Thus, ER stress
induces in situ lipid synthesis, leading to renal lipid accumulation and functional alterations. Future
pharmacological and/or dietary strategies must target renal ER stress to prevent kidney damage and
the progression of metabolic diseases.
Keywords: kidney; ER stress; lipogenesis
1. Introduction
Recent studies have associated abnormal lipid accumulation in the kidney, known as
fatty kidney [1], with kidney disease [1–5]. This abnormality has emerged as a common al-
teration in chronic kidney diseases and acute kidney injury [6–9]. Renal damage associated
with obesity involves uncontrolled free fatty acid (FFA) release from hypertrophic adipose
tissue, where its over-accumulation in renal tissue may induce cellular damage [10–13].
Increasing evidence suggests that renal ectopic lipid accumulation along with altered lipid
metabolism triggers kidney damage through lipotoxicity [14–17]. A study conducted by
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Koh et al. reported that in diabetic mice, renal AMP-activated protein kinase (AMPK)
and its active phosphorylated state are downregulated, leading to a reduction in fatty
acid oxidation [18]. Moreover, protein abundance of the lipogenic transcription factor
sterol regulatory element-binding protein 1 (SREBP-1) increases in the kidneys of obese
mice, exacerbating lipid accumulation [17–19]. These alterations have been associated with
obesity-related glomerulopathy, hyperfiltration, tubulointerstitial injury and fibrosis in
various experimental and human studies [20,21].
Endoplasmic reticulum (ER) stress is an important underlying mechanism in several
renal alterations that may induce glomerular and tubular damage, as this has been recently
observed in humans and in animal models [22–25]. ER stress is a cellular mechanism
activated in response to diverse insults, such as nutrient and oxygen deprivation, unfolded
and misfolded proteins in the ER, oxidative stress and nutrient excess [22,26,27]. To restore
cellular homeostasis, the ER activates a complex signaling pathway aimed to reestablish
normal cellular functions called the unfolded protein response (UPR) [28–30].
In mammalian cells, the UPR is composed of three major branches, including PKR-
like ER kinase (PERK), inositol-requiring enzyme 1 (IRE-1) and activating transcription
factor 6 (ATF6) [28,31]. One purpose of the UPR is to shut off general protein translation,
reducing the flux of proteins into the ER. The PERK pathway phosphorylates and inac-
tivates elongation initiation factor 2 alpha (eIF2alpha), halting protein synthesis [26,32],
the ATF6 pathways upregulate the expression of ER chaperones such as BiP, promoting
proper protein folding, and the IRE-1 alpha pathway activates ER-associated degradation
(ERAD) and X-box binding protein 1 (XBP1) splicing and translation in order to reestablish
cellular homeostasis [33]. However, when ER stress is not resolved, the UPR can induce
cell death [34]. In the liver, ER stress increases lipogenesis by the upregulation of genes
involved in lipid metabolism, inducing hepatic steatosis [35]. However, it is not known
whether ER stress in the kidney also induces in situ lipid accumulation and alters kidney
function. In order to evaluate the direct effect of ER stress in renal lipid metabolism, mice
without any other physiological alterations such as obesity or diabetes were administered
the N-linked glycosylation inhibitor tunicamycin, which induces ER stress, and euthanized
at 8 or 24 h after ER stress induction in order to evaluate time-dependent ultrastructural
morphology changes in renal tissue, renal lipid metabolism and AMPK activity.
2. Materials and Methods
2.1. Mice and Experimental Protocol
Male C57BL/6 mice (n = 6) aged 6–7 weeks old were obtained from the experimental
research department of our institute and were maintained in micro-isolator cages on a 12-h
light/dark cycle. All mice were given free access to food and water. To induce pharmaco-
logical ER stress, mice were administered a single intraperitoneal injection of 100 µg/mL
tunicamycin (Sigma, St. Louis, MO, USA) diluted in 150 mM dextrose at 1 g/Kg body
weight [36]. The control group (C) was injected with vehicle. Experimental groups were
administered with tunicamycin and euthanized 8 h (T8) or 24 h (T24) after injection (n = 6).
Tunicamycin is a competitive inhibitor of the N-acetylglucosamine phosphotransferase,
blocking N-glycosylation in the ER. Impaired N-glycosylation prevents adequate protein
folding in the ER, leading to misfolded protein accumulation and activation of the UPR.
The timing of sample collection was based on previous work indicating that at 8 h, UPR
activation is mostly at the mRNA level, whereas at 24 h, the increase is at the protein
level [37–39]. At the end of the study, mice were food-deprived for 6 h and euthanized by
CO2 asphyxiation. All animals were allocated into metabolic cages 8 h before euthanasia
for urine collection. Body weights were measured just before CO2 asphyxiation. The right
kidney was removed and weighed, quickly frozen in liquid nitrogen and stored at −70 ◦C
for molecular studies. Blood was obtained from the posterior vena cava using a 1 mL
syringe. Serum was separated by centrifugation for 10 min at 1800× g at 4 ◦C. One half
of the left kidney was blanched with phosphate buffer and fixed in 10% formalin. The
other half was fragmented into small pieces, immersed in 10% glutaraldehyde in cacodylate
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buffer pH 7.2 until fixation was completed for histological analysis. All animal procedures
were conducted in conformity with the Guide for the Care and Use of Laboratory Animals
of the NIH [40]. The protocol was submitted and approved by the institutional animal
ethics research committee (FNU-1917-18-20-1).
2.2. Renal Function Parameters
Serum creatinine, blood urea nitrogen (BUN) and serum uric acid were measured
with colorimetric kits in an automatized analyzer (UniCel DxC 600, Beckman Coulter,
Indianapolis, IN, USA). Urinary H2O2 excretion was determined by a fluorescent method
using Amplex Red (Invitrogen) [41]. The fluorescence was measured using excitation and
emission wavelengths of 571 and 585 nm, respectively, using a Synergy HT multimode
microplate reader (Biotek Instruments, Winooski, VT, USA).
2.3. Histological Analysis
The left kidney of each mouse was rapidly removed, sliced longitudinally and im-
mersed in ice-cold 10% paraformaldehyde in phosphate-buffered saline. After dehydration,
kidney slices were embedded in paraffin, sectioned at 4 µm and stained using hematoxylin
and eosin. Glomerular size and urinary space were measured in tissue sections stained
with H&E. The outline of 20 glomeruli from each animal was digitalized from the light
microscope using a video camera and a computer-based analysis system (magnification
200%) (Q/win-500, Leica, Milton Keynes, UK). Glomerular sections were displayed on
the computer screen, and their area was measured by an interactive procedure with an
image analysis software package. To normalize the structure for measuring, only glomeruli
in which both poles, vascular and tubular, were clearly seen were taken into account to
perform these determinations. To visualize neutral lipids, frozen kidney sections (8 µm)
were stained with Oil Red O (ORO; Sigma, St. Louis, MO, USA) and counterstained
with hematoxylin.
2.4. Apoptosis Analysis
Apoptosis was determined by using a terminal deoxynucleotidyl transferase-mediated
(TUNEL) assay. Detection of apoptotic cells was performed in 5 µm of formalin-fixed,
paraffin-embedded renal tissue by in situ TUNEL ApopTag® Plus Peroxidase, In Situ
Apoptosis Detection Kit (Chemicon-Millipore, Billerica, MA, USA) according to the manu-
facturer’s instructions. Cells were quantified in 6 fields of each mouse (magnification 40×).
TUNEL-positive cells were considered those that had nuclear condensation brown staining
and quantified as positive cells per square pixel. Results were presented as an average of
apoptotic cells ± SE per group with respect to the control mice, considering the control
group as 100%.
2.5. Electron Microscopy
To study the ultrastructural morphology of convoluted proximal renal tubules, small
kidney tissue fragments from the cortex were immersed in 10% glutaraldehyde dissolved
in cacodylate buffer pH 7.2 and post-fixed with osmium tetroxide, dehydrated in graded
ethyl alcohol solutions and embedded in Epon resin (London Resin Company, London,
UK). Thin sections from 70 to 90 nm were placed on copper grids, contrasted with lead and
uranium salts and examined with an FEI Technei electron microscope.
2.6. Biochemical Determinations
Serum glucose was assayed using enzymatic kits (DiaSys Diagnostic Systems GmbH,
Holzheim, Germany). The serum free fatty acid concentration was assayed with a Roche
FFA kit (Roche Applied Science). Serum glycerol was measured using the Free Glycerol
Reagent (Sigma). Serum insulin, leptin and adiponectin concentrations were measured by
radioimmunoassay (Millipore).
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2.7. RNA Extraction and mRNA Quantitation
Total RNA from kidney was extracted with TRIzol reagent (Invitrogen, Carlsbad, CA,
USA) following the manufacturer’s protocol. The RNA concentration was determined spec-
trophotometrically with a NanoDrop (Thermo Scientific, Wilmington, DE, USA). cDNA
synthesis was performed with 3 µg of total RNA using Oligo (dt)12–18 and M-MLV re-
verse transcriptase (Invitrogen), according to the manufacturer’s recommendations. All
genes were quantified using TaqMan assays (Applied Biosystems, Foster City, CA, USA).
TaqMan-based real-time quantification was performed in a LightCycler 480 Instrument
(Roche Molecular Biochemicals, Indianapolis, IN, USA). The cycling conditions were based
on the instructions provided by the manufacturer. The reference assay ID for each gene is
as follows: Kim-1 (Mm00506686_m1), ATF-6 (Mm01295317_m1), BiP (Mm00517691_m1),
CHOP (Mm00492097_m1), SREBP-1 (Mm00550338_m1), FAS (Mm00662319_m1) and Cy-
clophilin (Mm02342429_g1). For all genes, samples were run in triplicate in 96-well reaction
plates. Data were analyzed using LightCycler 480 software, and Ct was calculated by the
second derivate maximum method. Target gene expression levels were normalized to
cyclophilin mRNA abundance as the internal invariant control.
2.8. Protein Extraction, SDS/PAGE and Immunoblotting
Frozen tissues were homogenized in ice-cold RIPA buffer with a protease inhibitor
cocktail (Complete, Roche Applied Science) using a Kontes Pellet Pestle mixer (Thermo
Fisher Scientific, Rockford, IL, USA). The protein concentration was determined using the DC
protein assay kit (Bio-Rad Laboratories, Richmond, CA, USA). Tissue lysates (40 µg) were
combined with Laemmli sample buffer and separated by SDS-PAGE. After electrophoretic
separation, the proteins were electrotransferred to a PVDF membrane using a Mini Trans-Blot
Electrophoretic Transfer Cell (Bio-Rad), blocked and incubated overnight at 4 ◦C with the
following antibodies: ß-Actin, CHOP, ATF6, BiP, FASn, AMPK, p-AMPK (thr 172) (Santa Cruz
Biotechnology, Santa Cruz, CA, USA), eIF2α and p-eIF2α (ser 51) (Millipore-Upstate, Biller-
ica, MA, USA), IRE-1 and SREBP-1 (Abcam, Cambridge, MA, USA). After incubation with
secondary antibodies conjugated to horseradish peroxidase, chemiluminescence detection
was carried out using a chemiluminescent Western blotting kit (Immobilon Western Chemi-
luminescent HRP Substrate, Millipore). Digital images of the membranes were obtained by
a ChemiDoc MP densitometer and processed by Image Lab software (Bio-Rad). The results
are reported relative to ß-actin. A value of 1 was arbitrarily assigned to the control samples,
which were used as a reference for the other conditions.
2.9. Kidney Lipid Content
Total lipids were extracted from kidney tissue according to Folch et al. [42]. The
organic layer was dried under nitrogen gas and solubilized in isopropanol/Triton X-100
(10%) and then assayed for triglyceride concentration using an enzymatic kit (DiaSys).
Data were expressed as the amount of triglycerides per gram of wet weight.
2.10. Statistical Analysis
Data are presented as the mean ± SEM. Statistical analysis was performed using one-
way ANOVA with a post hoc test using Fisher’s LSD method for multiple comparisons,
using Prism 8 for Mac (GraphPad, San Diego, CA, USA). Differences were considered
statistically significant at p < 0.05 and are indicated by letters in the figures (a > b > c).
3. Results
3.1. ER Stress Is Associated with Alterations in Kidney Function and Structure
To understand whether the presence of ER stress is associated with renal dysfunction,
we induced ER stress in mice through a single i.p. low dose of tunicamycin and observed
the metabolic and morphological alterations after 8 and 24 h. We observed an increase
in serum creatinine, after 8 and 24 h of tunicamycin administration. However, serum
uric acid decreased after 8 h and increased significantly after 24 h compared to 8 h. BUN
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showed a slight increase without statistical significance (Figure 1A–C). The kidney injury
molecule 1 (Kim-1), an acute injury marker in renal proximal tubules, was analyzed
in order to determine if the induced ER stress modified this biomarker. Results from
the Kim-1 PCR showed that the low dose of tunicamycin administration significantly
increased Kim-1 mRNA expression in the 24 h group, confirming that ER stress induced
by tunicamycin caused tubular injury (Figure 1D). Additionally, the urinary concentration
of hydrogen peroxide was evaluated in order to determine if a reactive molecule derived
from molecular oxygen as part of ROS molecules was present. After 8 h of tunicamycin
treatment, a significant increase in oxidative stress was observed that was partially reduced
at 24 h (Figure 1E). Histopathological examination by H&E staining showed that an acute
exposition to tunicamycin modifies the kidney tubular structure compared with vehicle-
treated mice. We observed that ER induced a significant reduction in the diameter of
glomeruli as well as a decrease in the urinary space, suggesting that tunicamycin not
only induced tubular damage but also modified the glomerular structure (Figure 1F,G).
Eight hours after tunicamycin administration, few tubular lesions were observed, but
at 24 h, lesions increased. The lesions observed were loss of the epithelial brush border
and accumulation of debris in the luminal area, as well as vacuole formation (Figure 1H).
To evaluate renal lipid infiltration, frozen kidney sections were stained with Oil Red O.
As observed in Figure 2A–C, control mice did not show intracellular lipids nor visible
ultrastructural alterations. Interestingly, renal ER stress induced lipid droplet accumulation,
particularly in the renal cortex (Figure 2D). Electron microscopy study confirmed the
existence of cytoplasmic lipid vacuoles, dilatation of the rough endoplasmic reticulum
and an increase in lysosomes 8 h after tunicamycin administration (Figure 2E,F). After
24 h, numerous epithelial cells in the proximal convoluted tubules presented lipid droplets
(Figure 2G). Low- and high-power electron microscopy micrographs revealed an increased
number of dead cells specifically in the proximal convoluted tubule (Figure 2H,I). This
finding was confirmed by the TUNEL assay, where we observed that tunicamycin induced
apoptosis after 8h of administration, but this effect was exacerbated after 24 h (Figure 3A,B).
In the TUNEL assay, positive cells are shown by intense brown nuclear staining. On
the other hand, other cells showed cytoplasmic dissolution at the base in addition to
mitochondria with different abnormalities, such as matrix expansion, broken cristae and
electron-dense deposits. Some lysosomes were associated with empty vacuoles, forming
incipient autophagosomes (Figure 2H,I). Thus, endoplasmic reticulum stress in the kidney
was accompanied by an acute reduction in renal function and an altered morphology. Most
importantly, the presence of lipid droplets was observed as a distinctive characteristic that
ought to be studied further.
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Figure 1. Renal functional alterations associated with endoplasmic reticulum (ER) stress. Mice were administered a single 
i.p. injection of vehicle or tunicamycin (1 g/Kg body weight), and kidneys were obtained after 8 h (T8) or 24 h (T24). The 
following graphs display: serum creatinine (A), serum uric acid (B), BUN (C), Kim-1 gene expression (D), urinary hydro-
gen peroxide (E), morphometric analysis of glomerular diameter (F) and urinary space (G) in kidney sections stained with 
H&E (20× magnification). Values are means ± SEM, n = 4–6. Means without a common letter differ significantly, a > b > c 
(p < 0.05). (H) Representative micrographs of kidney H/E-stained sections from the different groups, in comparison with 
the control group (c), glomeruli are smaller in T8 and T24 groups, kidney from T8 group shows some proximal cortical 
tubules revisited by the flat damaged epithelium without apical microvilli (arrow), while kidney from the T24 group ex-
hibits numerous tubular epithelial cells with lipid cytoplasmic vacuoles (arrows). 
3.2. ER Stress Alters the Metabolic and Endocrine Parameters of Mice Treated with Tunicamy-
cin 
Endoplasmic reticulum stress has been identified as the underlying mechanism lead-
ing to the development of metabolic alterations in several organs [43]. Thus, we evaluated 
the effect of the acute induction of ER stress in systemic metabolism. We found no signif-
icant changes in either body or kidney weight after tunicamycin administration, main-
taining the kidney weight/body weight ratio (Table 1). However, tunicamycin-induced 
ER stress significantly reduced serum glucose, particularly after 24 h. 
Interestingly, serum insulin dramatically increased by 1.9- and 3.2-fold after 8 and 24 
h, respectively. In addition, FFA and glycerol also significantly increased by 1.1- and 0.7-
fold 8 h after tunicamycin administration and 0.6- and 1.0-fold after 24 h. Circulating lep-
tin and adiponectin concentrations increased by 4.5- and 0.7-fold, respectively, 8 h after 
tunicamycin administration. After 24 h, the circulating content of these adipokines dimin-
ished even though their levels remained significantly higher than in control mice (Table 
1). These results suggest that acute ER stress induced by tunicamycin causes hyperinsu-
linemia, increased lipolysis and adipokine secretion from adipose tissue. 
Figure 1. Renal functional alterations associated with endoplasmic reticulum (ER) stress. Mice were administered a single
i.p. injection of vehicle or tunica ycin (1 g/ g body eight), and kidneys ere obtained after 8 h (T8) or 24 h (T24). The
i raphs display: serum creatinine (A), serum uric acid (B), BUN (C), Kim-1 gen expression (D), urinary h drogen
p roxide (E), morphometric analysis of glomerular diameter (F) and urinary space (G) in kidney sections staine
E (20 agnification). alues are eans SE , n = 4–6. eans ithout a co on letter differ significantly, a > b > c
(p < 0.05). (H) Representative micrographs of kidney H/E-stained sections from the different groups, in comparison with
the control group (c), glomeruli are smaller in T8 and T24 groups, kidney from T8 group shows some proximal cortical
tubules revisited by the flat damaged epithelium without apical microvilli (arrow), while kidney from the T24 group exhibits
numerous tubular epithelial cells with lipid cytoplasmic vacuoles (arrows).
3.2. ER Stress Alters the Metabolic and Endocrine Parameters of Mice Treated with Tunicamycin
Endoplasmic reticulum stress has been identified as the underlying mechanism lead-
ing to the development of metabolic alterations in several organs [43]. Thus, we evaluated
the effect of the acute induction of ER stress in systemic metabolism. We found no signifi-
cant changes in either body or kidney weight after tunicamycin administration, maintaining
the kidney weight/body weight ratio (Table 1). However, tunicamycin-induced ER stress
significantly reduced serum glucose, particularly after 24 h.
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Figure 2. Altered kidney morphology induced by tunicamycin administration. (A) Frozen kidney 
sections of control mice stained with Oil Red O. (B) Low-power electron microscopy of kidneys 
from control mice. (C) High-power electron microscopy of kidneys from control mice. (D) Frozen 
kidney sections stained with Oil Red O 8 h after tunicamycin administration. Some convoluted 
tubules show red stained droplets in the cytoplasm (arrows) that correspond to lipid vacuoles. 
Inset shows high-power field tubule with some lipid droplets. (E) Low-power electron microscopy 
shows numerous cytoplasmic vacuoles in epithelial cells from convoluted tubules 8 h after tuni-
camycin administration. (F) High-power electron micrograph of proximal convoluted epithelial 
cell 8 h after tunicamycin administration. The distended rough endoplasmic reticulum (asterisks) 
is surrounded by mitochondria, lysosomes and lipid droplets (L). (G) Frozen section stained with 
Oil Red 24 h after tunicamycin administration. There are numerous epithelial cells from proximal 
convoluted tubules with red labeled lipid droplets. Inset shows high-power field tubule with nu-
merous lipid vacuoles. (H) Low-power electron microscopy micrograph from proximal convo-
luted tubule 24 h after tunicamycin administration. There are necrotic cells (arrow) intercalated 
with damaged epithelial cells with basal cytoplasmic dissolution (asterisks). (I) High-power micro-
graph from the same area shown in H. There is cytoplasmic dissolution with some mitochondria 
with a slightly expanded matrix (arrows) and lysosomes associated with vesicles conforming to 
autophagosomes (asterisk). 
3.3. Tunicamycin Causes ER Stress in the Kidney 
To evaluate the direct effect of a low-dose tunicamycin injection in the induction of 
ER stress markers in the kidney, we evaluated the expression of several UPR markers at 8 
and 24 h after tunicamycin administration. In response to increased protein load in the 
ER, the transcription factor XBP-1 is activated by mRNA splicing by IRE-1. XBP-1 along 
with the chaperone BiP is involved in the restoration of cellular homeostasis in response 
to acute ER stress. Our data clearly show that 8 h after tunicamycin administration, spliced 
XBP-1 and BiP mRNA rapidly increased by 12.4- and 31.6-fold, respectively (p < 0.001) 
(Figure 4A,B). Protein abundance of BiP presented a time-dependent increase by 14.5- and 
88-fold after 8 h and 24 h, respectively (Figure 4C,D). The time-dependent increase in BiP 
protein content despite a reduction in its mRNA abundance at 24 h reflects the selective 
Fig re 2. Altered kidney morphology induced by tunicamycin administration. (A) Frozen kidney
s ti i ith il Red O. (B) Low-power electron microscopy of kidneys from
c ntrol mice. (C) High-power electron microscopy of kidneys from control mice. (D) Frozen kidney
sections stained with Oil Red 8 h after tunicamycin ad inistration. Some convoluted tubules show
red stained droplets in the cytoplasm (arrows) that correspond to lipid vacuoles. Inset shows high-power
field tubule with some lipid droplets. (E) Low-power electron microscopy shows numerous cytoplasmic
vacuoles in epithelial cells from convoluted tubules 8 h after tunicamycin administration. (F) High-
power electron micrograph of proximal convoluted epithelial cell 8 h after tunicamycin administration.
The distended rough endoplasmic reticulum (asterisks) is surrounded by mitochondria, lysosomes and
lipid droplets (L). (G) Frozen section stained with Oil Red 24 h after tunicamycin administration. There
are num rous epithelial cells from proximal c nvoluted tubules w th red labeled lipid droplets. Inset
shows high-power field tubule with num rous lipid vacuoles. (H) Low-power electron microscopy
micrograph from proximal convoluted tubule 24 h after tunicamycin administration. There are necrotic
cells (arrow) intercalated with damaged epithelial cells with basal cytoplasmic dissolution (asterisks).
(I) High-power micrograph from the same area shown in H. There is cytoplasmic dissolution with
some mitochondria with a slightly expanded matrix (arrows) and lysosomes associated with vesicles
conforming to autophagosomes (asterisk).
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translation of high-priority proteins involved in the restoration of cellular homeostasis. 
Accordingly, protein abundance of IRE1 also increased in a time-dependent manner, in-
dicating increased XBP-1 mRNA processing (Figure 4D,E). The mRNA and protein abun-
dance of ATF6 and CHOP increased at 8 h as a response to pharmacologic ER stress but 
both mRNA and protein abundance were reduced at 24 h after tunicamycin exposure 
(Figure 4D,F–I). Consistently, phosphorylation of the translation initiation factor eIF2α 
increased 8 h after tunicamycin administration, indicative of a blockade of global protein 
synthesis. As observed with ATF6 and CHOP, eIF2α phosphorylation was reduced at 24 
h to a level similar to that in control mice (Figure 4D,J). These data clearly demonstrate 
that in response to impaired ER folding capacity due to tunicamycin administration, the 
kidney develops severe ER stress at 8 h which is partially resolved after 24 h due to acti-
vation of the adaptive UPR. 
 
Figure 3. ER stress-induced apoptosis in mouse kidneys. Mice were treated with a single i.p. injection of vehicle or tuni-
camycin (1 g/Kg body weight), and the kidney was obtained after 8 h (T8) or 24 h (T24). Kidney sections from tunicamycin-
treated groups were TUNEL-stained to identify apoptotic cells. Apoptotic cells were not identified in the control group, 
while apoptotic cells were observed after 8 h and 24 h of tunicamycin treatment (A). Assessment of the average percentage 
of TUNEL-positive cells (B). Values are means ± SEM, n = 4–6. Means without a common letter differ significantly, a > b > 
c (p < 0.05). 
Table 1. Body weight, kidney weight and biochemical parameters in mice treated with tunicamy-






Body weight, (g) 29.0 ± 1.6 32.3 ± 1.4 29.0 ± 0.8 
Kidney weight, (g) 0.196 ± 0.02 0.230 ± 0.01 0.205 ± 0.01 
Kidney weight/body weight (%) 0.67 0.71 0.72 
Glucose, mg/dl 232 ± 9.7 a 205 ± 15.0 a,b 170.8 ± 13.4 b 
Insulin (ng/mL) 2.01 ± 0.12 c 6.00 ± 0.22 b 8.44 ± 0.51 a 
NEFA (mM) 1.81 ± 0.1 c 3.79 ± 0.1 a 2.89 ± 0.3 b 
Glycerol (mM) 0.15 ± 0.004 b 0.26 ± 0.001 a 0.30 ± 0.002 a 
Leptin (ng/mL) 2.00 ± 0.17 b 11.02 ± 0.63 a 8.80 ± 0.80 a 
Adiponectin (µg/mL) 12.34 ± 2.1 b 21.14 ± 4.4 a 17.52 ± 2.5 a 
Values are means ± SE. Different letters in a row indicate significant difference (p < 0.05) a > b > c. 
NEFA—non-esterified fatty acids. 
ER stre s-induced apopto is in mouse kidneys. Mice were tr ated with a single .p. injection of vehicle or
tunicamycin (1 g/Kg body weight), an the kidney was ob ained after 8 h (T8) or 24 h (T24). Kidney sections from
tunicamycin-treated groups were TUNEL-stained to identify apoptotic cells. Apoptotic cells were not identified in the
control group, while apoptotic cells were observed after 8 h and 24 h of tunicamycin treatment (A). Assessment of the
average percentage of TUNEL-positive cells (B). Values are means ± SEM, n = 4–6. Means without a common letter differ
significantly, a > b > c (p < 0.05).
Table 1. Body weight, kidney weight and biochemical parameters in mice treated with tunicamycin
for 8 h and 24 h.
Parameter Control Tunicamycin8 h
Tunicamycin
24 h
Body weight, (g) 29.0 ± 1.6 32.3 ± 1.4 29.0 ± 0.8
Kidney weight, (g) 0.196 ± 0.02 0.230 ± 0.01 0.205 ± 0.01
Kidney weight/body weight (%) 0.67 0.71 0.72
Glucose, mg/dl 232 ± 9.7 a 205 ± 15.0 a,b 170.8 ± 13.4 b
Insulin (ng/mL) 2.01 ± 0.12 c 6.00 ± .22 b 8.4 ± 0.51 a
NEFA (mM) 1.81 ± 0.1 c 3.79 ± 0.1 a 2.89 ± 0.3 b
Glycerol (mM) 0.15 ± 0.004 b 0.26 ± 0.001 a 0.30 ± 0.002 a
Leptin (ng/mL) 2.00 ± 0.17 b 11.02 ± 0.63 a 8.80 ± 0.80 a
Adiponectin (µg/mL) 12.34 ± 2.1 b 21.14 ± 4.4 a 17.52 ± 2.5 a
Values are means ± SE. Different letters in a row indicate significant difference (p < 0.05) a > b > c. NEFA—non-
esterified fatty acids.
Interestingly, serum insulin dramatically increased by 1.9- and 3.2-fold after 8 and 24 h,
respectively. In addition, FFA and glycerol also significantly increased by 1.1- and 0.7-fold
8 h after tunicamycin administration and 0.6- and 1.0-fold after 24 h. Circulating leptin and
adiponectin concentrations increased by 4.5- and 0.7-fold, respectively, 8 h after tunicamycin
administration. After 24 h, the circulating content of these adipokines diminished even
though their levels remained significantly higher than in control mice (Table 1). These
results suggest that acute ER stress induced by tunicamycin causes hyperinsulinemia,
increased lipolysis and adipokine secretion from adipose tissue.
3.3. Tunicamycin Causes ER Stress in the Kidney
To evaluate the direct effect of a low-dose tunicamycin injection in the induction of ER
stress markers in the kidney, we evaluated the expression of several UPR markers at 8 and
24 h after tunicamycin administration. In response to increased protein load in the ER, the
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transcription factor XBP-1 is activated by mRNA splicing by IRE-1. XBP-1 along with the
chaperone BiP is involved in the restoration of cellular homeostasis in response to acute ER
stress. Our data clearly show that 8 h after tunicamycin administration, spliced XBP-1 and
BiP mRNA rapidly increased by 12.4- and 31.6-fold, respectively (p < 0.001) (Figure 4A,B).
Protein abundance of BiP presented a time-dependent increase by 14.5- and 88-fold after 8 h
and 24 h, respectively (Figure 4C,D). The time-dependent increase in BiP protein content
despite a reduction in its mRNA abundance at 24 h reflects the selective translation of high-
priority proteins involved in the restoration of cellular homeostasis. Accordingly, protein
abundance of IRE1 also increased in a time-dependent manner, indicating increased XBP-1
mRNA processing (Figure 4D,E). The mRNA and protein abundance of ATF6 and CHOP
increased at 8 h as a response to pharmacologic ER stress but both mRNA and protein
abundance were reduced at 24 h after tunicamycin exposure (Figure 4D,F–I). Consistently,
phosphorylation of the translation initiation factor eIF2α increased 8 h after tunicamycin
administration, indicative of a blockade of global protein synthesis. As observed with
ATF6 and CHOP, eIF2α phosphorylation was reduced at 24 h to a level similar to that in
control mice (Figure 4D,J). These data clearly demonstrate that in response to impaired ER
folding capacity due to tunicamycin administration, the kidney develops severe ER stress
at 8 h which is partially resolved after 24 h due to activation of the adaptive UPR.
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at 24 h (Figure 5D,E,G). These results indicated that SREBP-1 mRNA transcription and
translation were favored during ER stress, although FASn translation was probably halted
at 8 h in response to eIF2α phosphorylation. Interestingly, both total and phosphorylated
AMPK were significantly reduced in response to tunicamycin administration in a time-
dependent fashion (Figure 5F,G). AMPK is an intracellular energy sensor that induces
mitochondrial biogenesis and fatty acid oxidation in response to energy stress. Thus, the
reduction in AMPK abundance and activity during ER stress indicates an impairment in
fatty acid oxidation and energy metabolism in kidneys subjected to pharmacological ER
stress, favoring triglyceride accumulation and lipotoxicity.
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BiP and transcription factor XBP1-1 greatly increased to restore ER homeostasis, accom-
panied by a reduction in the phosphorylated form of eIF2α, allowing the translation of
most proteins. These changes were accompanied with a significant increase in SREBP-1
and FASn protein abundance and a reduction in AMPK phosphorylation, indicating a shift
in renal lipid metabolism from oxidation to synthesis, leading to increased accumulation of
triglycerides in the kidney.
The present study demonstrates that pharmacologically induced ER stress is associated
with acute alterations in kidney function and structure. Serum creatinine concentrations
significantly increased in the tunicamycin-injected group after 24 h. Higher serum creati-
nine is in agreement with previous studies, where tunicamycin increases serum creatinine
levels, in particular after 24 h of the administration of tunicamycin [46,47]. Interestingly,
Liu et al. [48] found in female mice that tunicamycin at a lower dose not alter kidney
function when the mice are young, but serum creatinine and BUN levels are significantly
increased when the mice age. Therefore, the gender and age of mice induced different
responses to tunicamycin treatment. On the other hand, uric acid showed a decrease after
8 h of tunicamycin treatment compared with levels founded after 24 h. Elevated serum uric
acid is a strong predictor of the development of fatty liver as well as metabolic syndrome.
A study conducted by Choi et al. in 2014 [49] demonstrated that uric acid induced ER stress
in hepatocytes, leading to SREBP-1c activation and triglyceride accumulation. These events
could occur in the kidney, since increasing evidence suggests that hyperuricemia is an
independent risk factor for the occurrence and development of kidney disease. In a study
conducted by Li et al., 2013, the authors identified that uric acid induced changes in rat
glomerular mesangial cells via ER stress [50]. In human renal tubular epithelial cells (HK-2)
treated with uric acid, morphological changes were observed and increased inflammatory
cytokines were present [51].
Oxidative protein folding in the endoplasmic reticulum is a significant source of hy-
drogen peroxide (H2O2), and for correct protein folding, the redox state of the ER must
be efficiently regulated. As such, several mechanisms with varying degrees of overlap
manage the redox state of the ER [52]. In order to analyze reactive molecules derived
from molecular oxygen, we evaluated hydrogen peroxide as a marker of ROS produc-
tion. Interestingly, hydrogen peroxide was significantly increased after 8 h of tunicamycin
treatment, and after 24 h, it returned to levels observed in the control group. This finding
indicates that hydrogen peroxide probably increased due to an uncontrolled ROS load
by tunicamycin that would lead to ER stress activating the unfolded protein response. In
order to prevent ROS overload, the ER needs a robust antioxidant mechanism.
A high-sensitivity and specific biomarker of acute kidney injury in early diagnosis is
Kim-1, a transmembrane glycoprotein [53], which is highly expressed in the differentiation,
proliferation and early damage of proximal renal tubular epithelial cells. In our study,
Kim-1 was significantly upregulated after 24 h of tunicamycin treatment. Even though no
statistical significance was observed between the control and 8 h tunicamycin treatment
groups, Kim-1 gene expression was three times higher in the 8 h treatment group, indicating
an alteration in renal tubular epithelial cells, since no expression should be observed
in healthy kidney tissue.
Clear evidence for acute renal damage induced by an acute low dose of tunicamycin
is the structural alterations at the cellular level. Histopathological evaluation of renal
microscopic images indicates that the glomerulus diameter and Bowman’s space undergo
alterations after tunicamycin exposure. Glomeruli diameter was reduced after 8 and 24 h
post-tunicamycin treatment, suggesting a possible role of the UPR in deactivation and
redifferentiation of mesangial cells. Previous reports have suggested that the UPR has
the potential to inhibit cell proliferation. For example, Brewer and Diehl [54] showed
that ER stress caused induction of the PERK-eIF2α pathway and consequent translational
suppression of cyclin D1, culminating in G0/G1 cell cycle arrest in NIH3T3 cells [55].
It is worth noting that all these metabolic alterations occurred very rapidly in response
to acute ER stress. Indeed, no significant differences in the composition of body weight
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or kidney weight were noted among groups during the 8 or 24 h tunicamycin challenge.
Despite the absence of changes in body weight, acute ER stress could alter the metabolic
activities of several organs, such as adipose tissue. As reported previously, acute ER stress
impairs adipose tissue endocrine functions [56]. The adipokines adiponectin and leptin ex-
ert important actions in the kidney and thus adipokine dysregulation during ER stress may
potentiate ER stress-induced alterations in kidney function. Adiponectin is cleared rapidly
from the circulation primarily by the liver and secondarily by the kidneys [57]. High
circulating adiponectin is strongly associated with reduced cardiovascular risk; however,
in obesity and type 2 diabetes, hypoadiponectinemia resulting from low adipose tissue
adiponectin secretion favors the development of insulin resistance and cardiovascular
disease [58]. Chronic kidney disease (CKD) is a unique condition that occurs with exceed-
ingly high insulin resistance and cardiovascular morbidity and mortality [59,60] and is
paradoxically associated with elevated plasma adiponectin [58]. In this study, adiponectin
levels increased in a time-dependent manner, as a result of increased adiponectin secretion
from adipose tissue and probably an ER stress-dependent reduction in kidney capacity for
clearing of circulating adiponectin. On the other hand, one of the main actions of leptin in
the brain is to regulate food intake [61]. Leptin also stimulates ß-oxidation of fatty acids,
as well as export of lipids from tissues through signaling events involving both central
(brain) and peripheral receptors [62,63]. Interestingly, ER stress is sufficient to inhibit leptin
signaling in cultured cells, whereas pharmacological inhibition of ER stress improves leptin
signaling [64,65]. In this study, tunicamycin significantly increased leptin serum levels after
8 h of tunicamycin treatment and remained significantly higher than the control group after
24 h. However, the beneficial or negative effect of increased adiponectin and leptin levels
in renal metabolism during acute ER stress needs to be further investigated. It has been
reported that ER stress regulates hepatic gluconeogenesis [66,67] and acute tunicamycin
treatment reduces blood glucose levels. Accordingly, to these previous observations, we
found that 24 h tunicamycin treatment decreased blood glucose (Table 1). The kidney
is a gluconeogenic organ and provides approximately 30% of circulating glucose during
fasting [68]. The role of renal ER stress in the reduction in circulating glucose during acute
tunicamycin challenge is unknown and warrants future studies.
We have previously demonstrated that acute tunicamycin administration induces ER
stress in adipocytes, leading to increased lipolysis [56]. Increased circulating FFA could
favor fatty infiltration in the kidney. Our results show that intraperitoneal administration of
a low dose of tunicamycin rapidly induced an ER stress response with increased circulating
FFA and glycerol after 8 and 24 h of tunicamycin treatment. These results are consistent with
the previous study by Bogdanovic et al., where they reported that tunicamycin induced an
ER stress response in adipose tissue that correlates with increasing circulating FFAs and
glycerol. However, Feng et al. [69] and Wu et al. reported a reduction in serum FFA after
tunicamycin treatment [36,69]. One possible reason for these discrepancies is the duration
of tunicamycin treatment, or the fed or fasted state of mice just before euthanasia [69]. The
increased circulating FFA content observed in mice administered with tunicamycin clearly
correlates with lipid droplets accumulation in proximal tubular cells and the confirmation
of cytoplasmic lipid vacuoles, in addition to the formation of incipient autophagosomes.
Mammalian cells activate autophagy to eliminate damaged proteins and organelles by
lysosomal degradation. The resulting amino acids, free sugars and fatty acids are recycled
to cope with the bioenergetic needs of the cell and for serving as building blocks for
new protein and organelle synthesis. Therefore, the process of autophagy provides a
protective role against accumulation of defective proteins and organelles and thus the
normal flux of the autophagic activity prevents the activation of cell death pathways.
However, under certain situations, excessive autophagy induces an impairment in the
completion of the autophagy process and over-digestion of cytoplasmic organelles contents,
leading to autophagic cell death [70]. Activation of ER stress has been associated with
disproportionate autophagy and the development of atherosclerosis and cardiovascular
disease [71]. In the present study, renal ER stress induced apoptosis in a time-dependent
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manner, where epithelial tubular cells were mainly affected. These results suggest that
epithelial tubular cells are particularly susceptible to acute ER stress.
Accumulating evidence supports the hypothesis that prolonged metabolic imbalance
of lipids leads to ectopic fat distribution in the peripheral organs (lipotoxicity), including
the kidney. Despite the significant impact of renal lipid metabolism in the progression
of kidney diseases, the pathophysiological consequences of renal lipid accumulation in
response to ER stress have only been partially been elucidated. This work paves the way for
novel pharmacological and non-pharmacological approaches for the treatment of kidney
diseases through mitigation of ER stress and prevention of lipid accumulation (Figure 6).
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5. Conclusions
Renal oxidative stress, apoptosis and lipotoxicity have been identified as the three
main alterations associated with mesangial expansion, tubular damage and glomeruloscle-
rosis. The elucidation of the molecular mechanisms linking renal metabolic alterations
with disease progression is fundamental to propose novel clinical biomarkers of early
renal damage and to develop innovative therapeutic approaches to prevent progression
to advanced stages of renal disease. The results of the present study point to renal endo-
plasmic reticulum stress as a highly significant mechanism that triggers the three main
alterations that lead to kidney disfunction and injury, i.e., (1) mitochondrial dysfunction
and reduced fatty acid oxidation, (2) unrestrained autophagia and (3) augmented SREBP-1
activity, increasing fatty acid synthesis. The concurrence of these abnormalities in the
kidney induces oxidative stress, apoptosis and lipotoxicity and may lead to chronic kidney
alterations (Figure 6). The efficient resolution of ER stress should be an important target for
future therapeutic approaches for preventing kidney diseases.
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